申请人:Despeyroux Pierre
公开号:US20060052426A1
公开(公告)日:2006-03-09
Compound corresponding to the general formula (I):
in which,
X represents an oxygen or sulphur atom; R
1
represents a C
1-10
alkyl group optionally substituted, a C
3-7
cycloalkyl, thienyl, pyridinyl or pyrimidinyl group; the thienyl groups being optionally substituted; the phenyl group being optionally substituted; R
2
represents a C
1-6
alkyl group optionally substituted, a C
3-7
cycloalkyl, piperidinyl, phenyl or pyridinyl group; the C
3-7
cycloalkyl and piperidinyl groups being optionally substituted; the phenyl and pyridinyl groups being optionally substituted; R
3
represents a hydrogen atom or a C
1-6
alkyl group optionally substituted with a C
3-7
cycloalkyl group; R
4
represents a hydrogen atom or a C
1-6
alkyl group; R
5
and R
5′
represent, independently of each other, a hydrogen or halogen atom, a hydroxyl or C
1-3
alkyl group; or R
5
and R
5′
form together an oxo or oxime group such as:
where R
7
represents a hydrogen atom or a C
1-3
alkyl; n represents an integer ranging from 0 to 3; and R
6
represents, independently of each other when n=2 or 3, a hydrogen or halogen atom, a hydroxyl, C
1-3
alkyl, C
1-3
alkoxy, C
1-3
fluoroalkyl or C
1-3
fluoroalkoxy group;
in the form of a base, of an addition salt with an acid, of a hydrate or of a solvate. therapeutic application.
对应于一般公式(I)的化合物:其中,X代表氧原子或硫原子;R1代表一个C1-10烷基基团,可选择性地取代,一个C3-7环烷基,噻吩基,吡啶基或嘧啶基团;噻吩基可选择性取代;苯基可选择性取代;R2代表一个C1-6烷基基团,可选择性地取代,一个C3-7环烷基,哌啶基,苯基或吡啶基团;C3-7环烷基和哌啶基可选择性取代;苯基和吡啶基可选择性取代;R3代表氢原子或一个C1-6烷基基团,可选择性地取代为C3-7环烷基团;R4代表氢原子或一个C1-6烷基基团;R5和R5'分别代表氢原子或卤素原子,羟基或C1-3烷基基团;或者R5和R5'共同形成一个醛基或肟基,如:其中R7代表氢原子或一个C1-3烷基;n表示一个介于0到3之间的整数;R6代表,当n=2或3时,独立地一个氢或卤素原子,一个羟基,C1-3烷基,C1-3烷氧基,C1-3氟烷基或C1-3氟烷氧基团;以碱、与酸形成的加合盐、水合物或溶剂化合物的形式。治疗应用。